{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:39:00Z","timestamp":1794940740202,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1038\/s41591-020-0945-x","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T16:04:22Z","timestamp":1594656262000},"page":"1264-1270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":315,"title":["Antibody-mediated inhibition of GDF15\u2013GFRAL activity reverses cancer cachexia in mice"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7971-1822","authenticated-orcid":false,"given":"Rowena","family":"Suriben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0522-9475","authenticated-orcid":false,"given":"Jared","family":"Higbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Oeffinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-4595","authenticated-orcid":false,"given":"Richard","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyani","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ayupova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9677-6273","authenticated-orcid":false,"given":"Pranali","family":"Taskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-4228","authenticated-orcid":false,"given":"Diana","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley R.","family":"Starck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-I Harry","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"McEntee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash D.","family":"Katewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-3809","authenticated-orcid":false,"given":"Marilyn","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avantika","family":"Kekatpure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodharan","family":"Lakshminarasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4393-1062","authenticated-orcid":false,"given":"Andre","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Olland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Haldankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Solloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer-Yuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrin A.","family":"Lindhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5998-4521","authenticated-orcid":false,"given":"Bernard B.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"945_CR1","first-page":"340","volume":"20","author":"MJ Tisdale","year":"2005","unstructured":"Tisdale, M. J. Molecular pathways leading to cancer cachexia. Physiol. (Bethesda) 20, 340\u20138 (2005).","journal-title":"Physiol. (Bethesda)"},{"key":"945_CR2","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C. & Fearon, K. C. H. Cancer-associated cachexia. Nat. Rev. Dis. Prim. 4, 17105 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"945_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.semcdb.2015.10.038","volume":"54","author":"KG Burfeind","year":"2016","unstructured":"Burfeind, K. G., Michaelis, K. A. & Marks, D. L. The central role of hypothalamic inflammation in the acute illness response and cachexia. Semin Cell Dev. Biol. 54, 42\u201352 (2016).","journal-title":"Semin Cell Dev. Biol."},{"key":"945_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles, J. M., Busquets, S., Stemmier, B. & Lopez-Soriano, F. J. Cancer cachexia: understanding the molecular basis. Nat. Rev. Cancer 14, 754\u2013762 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"945_CR5","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-\u03b2 superfamily cytokine MIC-1. Nat. Med. 13, 1333\u20131340 (2007).","journal-title":"Nat. Med."},{"key":"945_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcsm.12033","volume":"6","author":"L Lerner","year":"2015","unstructured":"Lerner, L. et al. Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J. Cachexia Sarcopenia Muscle 6, 317\u2013324 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"945_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ygyno.2010.05.032","volume":"118","author":"AC Staff","year":"2010","unstructured":"Staff, A. C. et al. Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer. Gynecol. Oncol. 118, 237\u201343 (2010).","journal-title":"Gynecol. Oncol."},{"key":"945_CR8","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/jcmm.12830","volume":"20","author":"C Li","year":"2016","unstructured":"Li, C. et al. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer. J. Cell Mol. Med. 20, 1420\u20136 (2016).","journal-title":"J. Cell Mol. Med."},{"key":"945_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"J Hsu","year":"2017","unstructured":"Hsu, J. et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 550, 255\u2013259 (2017).","journal-title":"Nature"},{"key":"945_CR10","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"S Mullican","year":"2017","unstructured":"Mullican, S. et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat. Med. 23, 1150\u20131157 (2017).","journal-title":"Nat. Med."},{"key":"945_CR11","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat. Med. 23, 1158\u20131166 (2017).","journal-title":"Nat. Med."},{"key":"945_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson, P. J. et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat. Med. 23, 1215\u20131219 (2017).","journal-title":"Nat. Med."},{"key":"945_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/382080a0","volume":"382","author":"JJ Treanor","year":"1996","unstructured":"Treanor, J. J. et al. Characterization of a multicomponent receptor for GDNF. Nature 382, 80\u20133 (1996).","journal-title":"Nature"},{"key":"945_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/42722","volume":"387","author":"RD Klein","year":"1997","unstructured":"Klein, R. D. et al. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387, 717\u201321 (1997).","journal-title":"Nature"},{"key":"945_CR15","doi-asserted-by":"publisher","first-page":"e47650","DOI":"10.7554\/eLife.47650","volume":"19","author":"J Lie","year":"2019","unstructured":"Lie, J. et al. Cryo-EM analyses reveal the common mechanism and diversification in the activation of RET by different ligands. Elife 19, e47650 (2019).","journal-title":"Elife"},{"key":"945_CR16","doi-asserted-by":"publisher","first-page":"35164","DOI":"10.1074\/jbc.M802543200","volume":"283","author":"V Parkash","year":"2008","unstructured":"Parkash, V. et al. The structure of the glial cell line-derived neurotrophic factor-coreceptor complex: insights into RET signaling and heparin binding. J. Biol. Chem. 283, 35164\u201372 (2008).","journal-title":"J. Biol. Chem."},{"key":"945_CR17","first-page":"3727","volume":"60","author":"G De Vita","year":"2000","unstructured":"De Vita, G. et al. Tyrosine 1062 of RET\u2013MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer Res. 60, 3727\u20133731 (2000).","journal-title":"Cancer Res."},{"key":"945_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jcsm.12077","volume":"7","author":"L Lerner","year":"2016","unstructured":"Lerner, L. et al. MAP3K11\/GDF15 axis is a critical driver of cancer cachexia. J. Cachexia Sarcopenia Muscle 7, 467\u201382 (2016).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"945_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"A Coll","year":"2020","unstructured":"Coll, A. et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444\u2013448 (2020).","journal-title":"Nature"},{"key":"945_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1198973","volume":"333","author":"SK Das","year":"2011","unstructured":"Das, S. K. et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 333, 233\u20138 (2011).","journal-title":"Science"},{"key":"945_CR21","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1158\/0008-5472.CAN-06-4585","volume":"67","author":"T Agustsson","year":"2007","unstructured":"Agustsson, T. et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res. 67, 5531\u20137 (2007).","journal-title":"Cancer Res."},{"key":"945_CR22","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/cncr.23802","volume":"113","author":"M Ryd\u00e9n","year":"2008","unstructured":"Ryd\u00e9n, M. et al. Lipolysis\u2014not inflammation, cell death, or lipogenesis\u2014is involved in adipose tissue loss in cancer cachexia. Cancer 113, 1695\u2013704 (2008).","journal-title":"Cancer"},{"key":"945_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans, W. J. et al. Cachexia: a new definition. Clin. Nutr. 27, 793\u2013799 (2008).","journal-title":"Clin. Nutr."},{"key":"945_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","volume":"28","author":"VWW Tsai","year":"2018","unstructured":"Tsai, V. W. W., Husaini, Y., Sainsbury, A., Brown, D. A. & Breit, S. N. The MIC-1\/GDF15\u2013GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell Metab. 28, 353 (2018).","journal-title":"Cell Metab."},{"key":"945_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nature25511","volume":"555","author":"CA Campos","year":"2018","unstructured":"Campos, C. A., Bowen, A. J., Roman, C. W. & Palmiter, R. D. Encoding of danger by parabrachial CGRP neurons. Nature 555, 617\u2013622 (2018).","journal-title":"Nature"},{"key":"945_CR26","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","volume":"178","author":"HH Luan","year":"2019","unstructured":"Luan, H. H. et al. GDF15 is an inflammation-induced central mediator of tissue tolerance. Cell 178, 1231\u20131244 (2019).","journal-title":"Cell"},{"key":"945_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nm.4093","volume":"22","author":"T Fukawa","year":"2016","unstructured":"Fukawa, T. et al. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia. Nat. Med. 22, 666\u2013671 (2016).","journal-title":"Nat. Med."},{"key":"945_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/MCO.0b013e32833c3c64","volume":"13","author":"L Holm","year":"2010","unstructured":"Holm, L. & Kjaer, M. Measuring protein breakdown in individual proteins in vivo. Curr. Opin. Clin. Nutr. Metab. Care. 13, 526\u2013531 (2010).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"945_CR29","doi-asserted-by":"publisher","first-page":"13640","DOI":"10.1523\/JNEUROSCI.1133-09.2009","volume":"29","author":"J Strelau","year":"2009","unstructured":"Strelau, J. et al. Progressive postnatal motoneuron loss in mice lacking GDF-15. J. Neurosci. 29, 13640\u201313648 (2009).","journal-title":"J. Neurosci."},{"key":"945_CR30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","volume":"174","author":"A Zeisel","year":"2018","unstructured":"Zeisel, A. et al. Molecular architecture of the mouse nervous system. Cell 174, 999\u20131014 (2018).","journal-title":"Cell"},{"key":"945_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"945_CR32","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288\u20134297 (2012).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-020-0945-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-020-0945-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-020-0945-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:03:29Z","timestamp":1684620209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-0945-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1038\/s41591-020-0945-x","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"27 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.L., A.W. and A.O. declare no direct competing financial interests. All other authors are, or were, employees of NGM Biopharmaceuticals and may hold stock or stock options in this company. NGM Biopharmaceuticals, Inc. has obtained a patent, entitled \u201cBinding proteins and methods of use thereof\u201d (US10174119B2), that discloses protein sequences of the anti-GFRAL antibodies, GFRAL\u2013antibody protein complexes and potential uses of those agents. J.T. and Y.W. are listed as inventors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}